Antiphosphatidylethanolamine Antibodies in Systemic Lupus Erythematosus

Abstract

Antiphosphatidylethanolamine antibodies (aPEA) were investigated in a population of 78 systemic lupus erythematosus (SLE) patients, by means of an enzyme-linked immunosorbent assay method. These antibodies are specifically directed against phosphatidylethanolamine, one of the zwitterionic phospholipids present in cell membranes. Antiphosphatidylethanolamine antibodies were found in 13 patients (16.6%). They were generally associated with lupus anticoagulant (two patients), antiphospholipid antibodies directed against anionic phospholipids (six patients), or both (four patients). In only one case, aPEA were the sole detectable antiphospholipid antibodies. Thrombosis, recurrent fetal loss, valvular disease or neurological involvement was present in most (11 of 13) of the patients with aPEA. It seems valuable to carry on further searches for these antibodies in SLE, since patients with aPEA are at higher risk of thrombosis and/or recurrent fetal losses than are patients with antiphospholipid antibodies (anticardiolipin, anti-anionic phospholipid and/or lupus anticoagulant) other than aPEA. Moreover, since aPEA can be the sole detectable antiphospholipid antibodies, they should be investigated in SLE with thrombosis when neither lupus anticoagulant nor anticardiolipin antibodies can be demonstrated.

Keywords

Antiphospholipid antibodies Antiphosphatidylethanolamine antibodies Anticardiolipin antibodies Systemic lupus erythematosus Thrombosis

Get full access to this article

View all access options for this article.

References

Zwaal Rfa. Membrane and blood involvement in blood coagulation. Biochim Biophys Acta 1978; 515: 163-205.

Feinstein DI , Rapaport SI Acquired inhibitors of blood coagulation . Prog Haemost Thromb 1972; 1: 75-95.

Pengo V. , Thiagarajan P. , Shapiro SS , Heine MJ Immunological specificity and mechanism of action of IgG lupus anticoagulants . Blood 1987; 70: 69-76.

Harris EN , Gharavi AE , Patel SP , Hughes Grv. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in SLE. Lancet 1983; ii: 1211-4.

Hughes Grv , Harris EN , Gharavi AE The anticardiolipin syndrome. J Rheumatol 1986 ; 13: 486-9.

Harris EN Antiphospholipid antibodies. Br J Haematol 1990; 74: 1-9.

Branch DW , Rote NS , Dostal DA , Scott JR Association of lupus anticoagulant with antibody to phosphatidylserine . Clin Immunol Immunopathol 1987; 42: 63-75.

Gharavi AE , Harris EN , Asherson RA , Hughes GR Anticardiolipin antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis 1987; 46:1-6.

Weidmann CE , Wallace DJ , Peter JB , Knight PJ , Bear MB , Klinenberg JR Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 1988; 15: 74-9.

10.

Falcon CR , Hoffer AM , Carreras LO Antiphosphatidylinositol antibodies as markers of the antiphospholipid syndrome . Thromb Res 1990; 63: 321-2.

11.

Lafer EM , Rauch J. , Andrzejewski C. et al. Polyspecific monoclonal lupus antibodies reactive with polynucleotides and phospholipids. J Exp Med 1981; 153: 897-909.

12.

Levy RA , Gharavi AE , Sammaritano LR , Habina L. , Lockshin MD Fatty acid chain is a critical epitope for antiphospholipid antibody . J Clin Immunol 1990; 10: 141-4.

13.

Rauch J. , Meng QH , Tannenbaum H. Lupus anticoagulant and antiplatelet properties of human hybridoma antibodies . J Immunol 1987 ; 139: 2598-604.

14.

Rauch J. , Tannenbaum M. , Tannenbaum H. et al. Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem 1986; 261: 9672-7.

15.

Staub HL , Harris EN , Khamashta MA , Savidge G. , Chahade WH , Hughes Grv. Antibody to phosphatidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann Rheum Dis 1989; 48: 166-9.

16.

Qamar T. , Gharavi AE , Levy RA , Lockshin MD Lysophosphatidylethanolamine is the antigen to which apparent antibody to phosphatidylethanolamine binds. J Clin Immunol 1990; 10: 200-3.

17.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of SLE. Arthritis Rheum 1982; 25: 1271-7.

18.

Exner T. , Triplett DA , Taberner D. , Machin SJ Guidelines for testing and revised criteria for lupus anticoagulants - SSC subcommittee for the standardization of lupus anticoagulants. Thromb Haemostas 1991; 65: 320-2.

19.

Harris EN The second international anti-cardiolipin standardization workshop/ The Kingston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-84.

20.

Karmochkine M. , Cacoub P. , Piette JC , Godeau P. , Boffa MC Antiphosphatidylethanolamine antibody as the sole antiphospholipid antibodies in systemic lupus erythematosus with thrombosis . Clin Exp Rheum 1992; 10: 603-5.

21.

Falcon CR , Hoffer AM , Carreras LO Evaluation of the clinical and laboratory associations of antiphosphatidylethanolamine . Thromb Res 1990; 63: 321-2.

22.

Rauch J. , Janoff AS Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Natl Acad Sci USA 1990; 87: 4112-4.

23.

Alarcon-Segovia D. , Delezé M. , Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus—a prospective analysis of 500 consecutive patients. Medicine 1989; 68: 353-65.

24.

Love PE , Santoro SA Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990; 112: 682-98.